Literature DB >> 24981519

Multi-drug resistant Mycobacterium tuberculosis complex genetic diversity and clues on recent transmission in Punjab, Pakistan.

Memona Yasmin1, Michel K Gomgnimbou2, Rubina T Siddiqui1, Guislaine Refrégier3, Christophe Sola4.   

Abstract

Multi-Drug Resistant Tuberculosis (MDR-TB), i.e. bacilli resistant to rifampicin (RIF) and isoniazid (INH), is a major Public Health concern in Pakistan according to WHO estimates (3.5% and 32% of new and retreated cases, respectively). Previous Pakistanis reports identified a correlation between being MDR and belonging to Beijing or EAI lineages in one study, and belonging to "H4"-Ural Euro-American sublineage in another study. In addition, MDR-TB transmission was suspected in Karachi. We tested MDR characteristics on a Punjab sample of 278 clinical isolates (without selection for Multi-Drug Resistance) including new and retreated cases collected from 2008 to 2012. All samples were characterized by a new, microbead-based method named "TB-SPRINT" (molecular diagnostic including spoligotype identification, and genetic resistance determinants to first-line anti-TB drugs RIF and INH). Isolates from 2011 to 2012 (n=100) were further analyzed using 24-loci MIRU-VNTR. We detected 8.7% MDR isolates (CI95%=[5.0; 12.5]), mainly among CAS lineage that predominates in this central-East region of Pakistan. Out of 20 MDR-TB cases, 12 different TB-SPRINT profiles were identified, limiting the suspicion of MDR-TB transmission. 24 MIRU-VNTR confirmed the unrelatedness of isolates with different TB-SPRINT profiles and discriminated 3 isolates with identical TB-SPRINT profiles. In conclusion, our study did not confirm any of the correlations between Multi-Drug Resistance and lineage or sublineage in Punjab, Pakistan. MDR-TB isolates were diverse indicating that transmission is not pervasive. TB-SPRINT proved useful as a first step for detecting MDR-TB likely transmission events, before more extensive genotyping such as 15 or 24 MIRU-VNTR and thorough epidemiological investigation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genotypic drug susceptibility testing; MDR-TB; Molecular epidemiology; Rifampin

Mesh:

Substances:

Year:  2014        PMID: 24981519     DOI: 10.1016/j.meegid.2014.06.017

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran.

Authors:  Noormohamad Mansoori; Farzam Vaziri; Sirus Amini; Sharareh Khanipour; Shahin Pourazar Dizaji; Masoumeh Douraghi
Journal:  Infect Drug Resist       Date:  2020-07-01       Impact factor: 4.003

2.  Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT.

Authors:  Barbara Molina-Moya; Michel Kiréopori Gomgnimbou; Carmen Lafoz; Alicia Lacoma; Cristina Prat; Guislaine Refrégier; Sofia Samper; Jose Dominguez; Christophe Sola
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Introducing the Best Six Loci in Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat (MIRU-VNTR) Typing for Mycobacterium Tuberculosis Genotyping.

Authors:  Mahdis Ghavidel; Keyvan Tadayon; Nader Mosavari; Kimiya Nourian; Hamid Reza BahramiTaghanaki; Gholam Reza Mohammadi; Mohammad Rashtibaf; Kiarash Ghazvini
Journal:  Rep Biochem Mol Biol       Date:  2019-10

4.  Genomics and Machine Learning for Taxonomy Consensus: The Mycobacterium tuberculosis Complex Paradigm.

Authors:  Jérôme Azé; Christophe Sola; Jian Zhang; Florian Lafosse-Marin; Memona Yasmin; Rubina Siddiqui; Kristin Kremer; Dick van Soolingen; Guislaine Refrégier
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

5.  Spoligotyping analysis of Mycobacterium tuberculosis in Khyber Pakhtunkhwa area, Pakistan.

Authors:  Sajid Ali; Muhammad Tahir Khan; Khan Anwar Sheed; Muhammad Mumtaz Khan; Fariha Hasan
Journal:  Infect Drug Resist       Date:  2019-05-20       Impact factor: 4.003

6.  Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis.

Authors:  Shima Hadifar; Abolfazl Fateh; Vahid Pourbarkhordar; Seyed Davar Siadat; Shayan Mostafaei; Farzam Vaziri
Journal:  BMC Infect Dis       Date:  2021-01-04       Impact factor: 3.090

7.  Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.

Authors:  Irfan Ullah; Arshad Javaid; Zarfishan Tahir; Obaid Ullah; Aamer Ali Shah; Fariha Hasan; Najma Ayub
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.